Introduction
The Verner-Morrison syndrome (Verner and Morrison, 1958) consisting of watery diarrhoea, hypokalaemia and achlorhydria or hypochlorhydria, is now recognized as being frequently associated with non-beta islet cell tumours of the pancreas, although cases have subsequently been described in association with phaeochromocytoma, ganglioneuroblastoma, and bronchial carcinoma (Said and Faloona, 1975) . The clinical features of the syndrome result from the hormone-like effect of polypeptides produced by the tumour cells. Vasoactive intestinal polypeptide (VIP) is thought to be the most likely cause of the syndrome (Bloom, Polak and Pearse, 1973) as the pharmacological effects of the hormone correlate well with the clinical symptoms and signs. VIP was first isolated from small intestine of pig in 1970 (Said and Mutt, 1970) and was subsequently synthetized (Bodansky, Klausner and Said, 1973) . Biological actions of VIP have been described but its physiological stimulus for release have yet to be discovered. Since the measurement of VIP by radioimmunoassay, elevated plasma levels of VIP have been found in over 95%4 of cases presenting with the syndrome (Said and Faloona, 1975) .
A patient is now described whose clinical features correlated well with the classical description of the syndrome. It will be shown that the cyclical nature of her symptoms were associated with cyclical release of VIP from tumour cells. Changes in jejunal fluid and electrolytes will be described and the possible value of serial VIP estimations in long-term followup after treatment discussed.
Case report
A 66-year-old female, presented with a 6-week history of profuse watery diarrhoea, anorexia, vomiting, weight-loss and extreme weakness. During the previous eighteen months similar episodes had been occurring at 6-week intervals, usually preceded by facial flushing. Her Chest X-ray, barium enema, stool cultures, Widal and Brucella titres were all normal. Sigmoidoscopy showed a normal rectal mucosa with watery stool content. The electrocardiograph showed prominent U waves consistent with hypokalaemia.
On the first admission she was treated symptomatically with fluid and electrolyte replacement. The diarrhoea settled spontaneously and the plasma biochemistry returned to normal. Over the next 4 months however, the symptoms recurred on four occasions and on each occasion they were associated with hypokalaemia and hypercalcaemia.
The ESR remained elevated at 100 mm/hr. A pan-aortogram with selective catheterization of the coeliac and superior mesenteric artery demonstrated a tumour in the tail of the pancreas (Fig. 2) Small intestinal absorption was measured by a perfusion study using a triple lumen tube (Russell et al., 1973) . This showed diminished water absorption and a net secretion of sodium and chloride compared with a standard control group studied previously (Table 1) . Jejunal aspiration before and after surgery showed marked reduction in jejunal secretion following operation (Table 2) . (Fig. 3) . Plasma estimations for other polypeptides (gastrin, secretin, insulin and glucagon) were all normal (Table 3) .
Tumour histology showed a pancreatic islet cell apudoma of the D-cell type (Fig. 4) 
Discussion
This patient satisfies the criteria of the VernerMorrison syndrome which include watery diarrhoea, hypokalaemia and achlorhydria or hypochlorhydria. Associated features may include hyperglycaemia and hyperinsulinism, hypercalcaemia, hypotension, flushing, metabolic acidosis and renal failure (Kerins, Said and Vane, 1970) . The induced hypokalaemia and dehydration may be severe and life-threatening. Diagnosis is often delayed. In this case, a pancreatic tumour was found and the symptoms were abolished by surgical removal of this tumour.
The cyclical peaks in VIP seen in Fig. 1 showed excellent correlation with recurrence of diarrhoea and weakness. The peak of VIP (Fig. 3) produced during surgery was related to manipulation of the tumour, and caused a profound and immediate fall in the systolic and diastolic pressure of 20 mmHg. This tends to confirm the supposition that a vasoactive substance, e.g. VIP, was contained in the tumour, and that cyclical release of this substance in response to an unknown stimulus was responsible for the profuse diarrhoea. The hypothesis is supported by the absence of symptoms in association with very low levels of VIP following surgery, although it is possible that other vasoactive substances such as prostaglandins, which could add to, or even account for the symptoms were also being produced by the tumour.
The striking dehydration, hypokalaemia and hyponatraemia seen in this case were due to the profuse and extremely watery diarrhoea so characteristic of the disease. Both increased small intestinal secretion and diminished absorption of water and electrolytes have been suggested as the mechanism for the fluid loss. It has been shown that VIP stimulates adenylate cyclase and cyclic-AMP in intestinal mucosa in a similar pattern to cholera toxin and prostaglandins, with the production of an intestinal secretion of water and electrolyte (Schwartz et al., 1974) . Pancreatic secretion, particularly of bicarbonate rich juice, is also known to occur (Barbezat and Grossman, 1971 ) and may account for the severe acidosis present during exacerbations. It is noteworthy that the studies ofjejunal perfusion and secretion confirm the excessive secretory state of the small bowel. The amount of small gut secretion was significantly diminished following surgery.
Although the Verner-Morrison syndrome presents a diagnostic challenge it gives one of those rare opportunities in oncology whereby the use of a biological marker can be used to monitor the progress of a tumour and the effect of treatment. Serial plasma VIP estimations have been carried out in this case, and it is hoped that any tumour recurrence will be diagnosed at an early stage, before the symptoms of diarrhoea recur. Chemotherapy with streptozotocin would then probably be the treatment of choice. This drug, which appears to be a specific islet cell toxin, has been shown to be effective in combination with steroids in controlling the symptoms produced by these tumours even in cases which are inoperable (Kahn et al., 1975) . a pancreatic islet cell apudoma. from intestinal polypeptide (VIP)
